|
Re: as subtypes of her2+ breast cancer discovered, a particularly nasty one ID'd
14% only? Wow! How do we know whether our tumors overexpress LMW cyclin E? I'm thinking now that with all your recent postings about HER-2+/ER+ interactions, I'd sure like it for my tumor to be tested for this and p95...
Has anyone here ever tried to contact a researcher directly to see if they could test your tumor? I have my pathology slides with me (my breasts reduced to a small Fedex box) and will meet up with a pathologist next week to look at them. I'd love to get more information out of them if I can...
Thanks Lani for all your postings!
Marcia
__________________
ER+ (30%)/PR-/HER-2+, stage 3
Diagnosed on 02/18/09 at 38 with a huge 12x10 cm tumor, after a 6 month delay. Told I was too young and had no risk factors. Found swollen node during breastfeeding.
March-August 09: neo-adjuvant chemo, part of a trial at Stanford (4 DD A/C, 4 Taxotere with daily Tykerb), loading dose of Herceptin
08/12/09 - bye bye boobies (bilateral mastectomy)
08/24/09 - path report shows 100 % success in breast tissue (no cancer there, yay!), 98 % success in lymphatic invasion, and even though 11/13 nodes were still positive, > 95 % of the tumor in them was killed. Hoping for the best!
September-October 09: rads with daily Xeloda
02/25/10 - Cholecystectomy
05/27/10 - Bone scan clear
06/14/10 - CT scan clear, ovarian cyst found
07/27/10 - Done with Herceptin!
02/15/11 - MVA-BN HER-2 vaccine trial
03/15/11 - First CA 15-3: 12.7 and normal, yay!
10/01/11 - Bone scan and CT scan clear, fatty liver found
now on Tamoxifen and Aspirin
|